Market Overview The global Subcutaneous Immunoglobulin Market is witnessing substantial expansion driven by the growing prevalence of primary immunodeficiency disorders, increasing incidence of autoimmune diseases, and rising preference for home-based treatment options. Subcutaneous immunoglobulin (SCIG) therapy has emerged as an effective alternative to intravenous immunoglobulin...